Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Gets $100K SBIR Grant from NIEHS to Analyze Networks from Toxicogenomics Data

NEW YORK, May 24 (GenomeWeb News) - GeneGo has received a Phase I SBIR grant from the National Institute of Environmental Health Sciences to analyze cellular signaling networks activated in response to drugs and toxins, the St. Joseph, Mich.-based company said today.


The company did not list the amount of the grant, but according to an NIH database, GeneGo received a $98,648 grant from NIEHS this month for a 6-month project, entitled "Networks From Toxicogenomics Gene Expression Data."


In the first phase of the project, GeneGo will reanalyze publicly available data using its MetaCore platform.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.